米R-122对癌症的影响
Shijie Wu1, Yiwen Wu1, Sijun Deng1
1School of Pharmaceutical Science, Hengyang Medical College, University of South China, Hengyang, Hunan, P.R. China.
Current pharmaceutical biotechnology
|January 23, 2024
概括
像miR-122这样的microRNAs (miRNAs) 调节基因表达,在癌症发育中至关重要. 失调的miR-122显示出作为癌症诊断和治疗的生物标志物的潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 微RNAs (miRNAs) 是简短的,保存的非编码RNAs,在转录后调节基因表达.
- 失调的miRNAs在各种癌症中充当瘤基因或瘤抑制剂.
- 通过调节点基因和途径,miR-122涉及多种瘤类型的致癌性.
研究的目的:
- 审查miR-122在基因调节和瘤生物学中的作用.
- 讨论miR-122调节失调对人类恶性瘤的影响.
- 探索miR-122向治疗的潜力及其作为生物标记物的实用性.
主要方法:
- 文献综述侧重于miR-122表达和癌症中的功能.
- 对研究miR-122的调节机制和对瘤发生的影响的研究分析.
- 关于miR-122在各种人类癌症中的作用的综合证据.
主要成果:
- 通过调节基因和信号通路,miR-122显著影响致癌性.
- 在各种人类恶性瘤中观察到miR-122的失调.
- 在瘤学中,miR-122具有作为诊断和治疗生物标志物的潜力.
结论:
- miR-122在癌症的发展和进展中起着至关重要的作用.
- 向miR-122为新型癌症疗法提供了潜力.
- 将miR-122与传统生物标志物的结合可以改善癌症诊断和患者的治疗结果.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


